Yumanity Therapeutics, Inc. (NASDAQ:YMTX – Get Free Report) shares rose 1.8% during trading on Thursday . The stock traded as high as $0.50 and last traded at $0.49. Approximately 51,830 shares traded hands during mid-day trading, a decline of 89% from the average daily volume of 473,083 shares. The stock had previously closed at $0.48.
Yumanity Therapeutics Trading Up 1.8 %
The company has a fifty day moving average of $0.55 and a 200-day moving average of $2.26. The company has a market capitalization of $5.29 million, a price-to-earnings ratio of -0.16 and a beta of 0.32.
Yumanity Therapeutics Company Profile
Yumanity Therapeutics Inc, a clinical stage biopharmaceutical company, engages in the research and development of treatments for neurodegenerative diseases caused by protein misfolding. The company focuses on discovering disease-modifying therapies to treat neurodegenerative diseases, including Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, amyotrophic lateral sclerosis, and frontotemporal lobar degeneration.
Recommended Stories
- Five stocks we like better than Yumanity Therapeutics
- What Investors Need to Know to Beat the Market
- The Real Reason Michael Burry is Buying Physical Gold
- Airline Stocks – Top Airline Stocks to Buy Now
- Investing in 5G Stocks: Still an Opportunity
- What is Short Interest? How to Use It
- Cisco Systems Rebound is On: Double-Digit Upside to Come
Receive News & Ratings for Yumanity Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Yumanity Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
